Literature DB >> 12413416

Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system.

Marc J Ruitenberg1, Ruben Eggers, Gerard J Boer, Joost Verhaagen.   

Abstract

The use of viral vectors as agents for gene delivery provides a direct approach to manipulate gene expression in the mammalian central nervous system (CNS). The present article describes in detail the methodology for the injection of viral vectors, in particular adeno-associated virus (AAV) vectors, into the adult rat brain and spinal cord to obtain reproducible and successful transduction of neural tissue. Surgical and injection procedures are based on the extensive experience of our laboratory to deliver viral vectors to the adult rat CNS and have been optimized over the years. First, a brief overview is presented on the use and potential of viral vectors to treat neurological disorders or trauma of the CNS. Next, methods to deliver AAV vectors to the rat brain and spinal cord are described in great detail with the intent of providing a practical guide to potential users. Finally, some data on the experimental outcomes following AAV vector-mediated gene transfer to the adult rat CNS are presented as is a brief discussion on both the advantages and limitations of AAV vectors as tools for somatic gene transfer. Copyright 2002 Elsevier Science (USA)

Entities:  

Mesh:

Year:  2002        PMID: 12413416     DOI: 10.1016/s1046-2023(02)00222-0

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  13 in total

1.  Amyloid precursor protein and tau transgenic models of Alzheimer's disease: insights from the past and directions for the future.

Authors:  Naruhiko Sahara; Jada Lewis
Journal:  Future Neurol       Date:  2010-05-01

2.  Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.

Authors:  Matthew R J Mason; Erich M E Ehlert; Ruben Eggers; Chris W Pool; Stephan Hermening; Angelina Huseinovic; Eric Timmermans; Bas Blits; Joost Verhaagen
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

Review 3.  The potential application of gene therapy in the treatment of traumatic brain injury.

Authors:  Fang Shen; Liang Wen; Xiaofeng Yang; Weiguo Liu
Journal:  Neurosurg Rev       Date:  2007-08-09       Impact factor: 3.042

4.  The assessment of adeno-associated vectors as potential intrinsic treatments for brainstem axon regeneration.

Authors:  Ryan R Williams; Damien D Pearse; Patrick A Tresco; Mary Bartlett Bunge
Journal:  J Gene Med       Date:  2012-01       Impact factor: 4.565

5.  Long-term adeno-associated viral vector-mediated expression of truncated TrkB in the adult rat facial nucleus results in motor neuron degeneration.

Authors:  Joris De Wit; Ruben Eggers; Robert Evers; Eero Castrén; Joost Verhaagen
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

6.  Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system.

Authors:  Erich M Ehlert; Ruben Eggers; Simone P Niclou; Joost Verhaagen
Journal:  BMC Neurosci       Date:  2010-02-18       Impact factor: 3.288

7.  Involvement of ERK2 in traumatic spinal cord injury.

Authors:  Chen-Guang Yu; Robert P Yezierski; Aashish Joshi; Kashif Raza; Yanzhang Li; James W Geddes
Journal:  J Neurochem       Date:  2010-01-12       Impact factor: 5.372

Review 8.  Gene therapy in epilepsy.

Authors:  Véronique Riban; Helen L Fitzsimons; Matthew J During
Journal:  Epilepsia       Date:  2008-08-19       Impact factor: 5.864

9.  Crystalline magnetic carbon nanoparticle assisted photothermal delivery into cells using CW near-infrared laser beam.

Authors:  Ling Gu; Ali R Koymen; Samarendra K Mohanty
Journal:  Sci Rep       Date:  2014-05-29       Impact factor: 4.379

10.  Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy.

Authors:  Rachael A Powis; Evangelia Karyka; Penelope Boyd; Julien Côme; Ross A Jones; Yinan Zheng; Eva Szunyogova; Ewout Jn Groen; Gillian Hunter; Derek Thomson; Thomas M Wishart; Catherina G Becker; Simon H Parson; Cécile Martinat; Mimoun Azzouz; Thomas H Gillingwater
Journal:  JCI Insight       Date:  2016-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.